Local view for "http://wifo5-04.informatik.uni-mannheim.de/drugbank/resource/drugs/DB05359"
| Predicate | Value (sorted: default) |
|---|---|
| rdfs:label |
"VEC-162"
|
| rdf:type | |
| drugbank:description |
"VEC-162 is a melatonin agonist under development for the treatment of sleep disorders (insomnia, circadian rhythm sleep disorders) and mood disorders (including depression). Vanda licensed VEC-162 from Bristol-Myers Squibb Company in 2004. Vanda has completed phase II for VEC-162 in insomnia and has initiated a phase III trial. "
|
All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines3/drugbank_small.nt
The resource does not appear as an object